NICHOLE HOLLAND: Open Payments
NPI 1588202600 · DELMAR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 22 payments from 8 companies in 2025. Trend: 2023 $532 · 2024 $79 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $145 |
| ABBVIE INC. | 4 | $91 |
| Aimmune Therapeutics, Inc. | 2 | $65 |
| Phathom Pharmaceuticals, Inc. | 3 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
| Ardelyx, Inc. | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Madrigal Pharmaceuticals | 1 | $23 |
Products named: TREMFYA, VOWST, MAVYRET, VOQUEZNA, ENTYVIO, IBSRELA, LINZESS, XIFAXAN.
Industry payments across MD — which companies pay providers there.
